Target intelligence / Profile preview

TEC (as annotated in available gene chip resource) (TEC)

Target
TEC
01

Overview

ENSG00000279590 is a genomic locus annotated as "TEC" or "AC005786.4" in curated gene databases, but is otherwise uncharacterized and not considered a therapeutic target. There is no reliable information on its molecular family, biological function, or disease relevance, and it is listed in major resources as "uncategorized" or a "novel transcript"[3][7]. Current evidence suggests this is not an established protein-coding gene or clinically actionable molecular entity.

Other names
AC005786.4

Beyond the preview

Go deeper on TEC (as annotated in available gene chip resource) (TEC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TEC (as annotated in available gene chip resource) (TEC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call